secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0000950170-25-050485
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health exercises option for Neutropenia license; accelerates $500K milestone
--------------------------------------------------------------------------------

- Exercised Exclusive Option on March 28, 2025 to license Neutropenia indication of Entolimod from Statera.
- Accelerated first milestone payment of $500,000 for IND and Phase 2 study for Neutropenia.
- Issued 55,704 common shares and 131.1267 Series A Preferred shares to Statera and Avenue as consideration.
- Obligated to develop Neutropenia indication at own cost and pay future milestones up to $2.75M for this indication.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025050485/0000950170-25-050485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025050485/tivc-20250328.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-050485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer